Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Chronic Subdural Hematoma Embolization With Detachable Coils

NCT: NCT07291427 · RECRUITING

NCT IDNCT07291427
StatusRECRUITING
Start Date2026-06-02
Completion2028-09-01
SponsorIcahn School of Medicine at Mount Sinai (OTHER)
First posted
Last updated

Brief Summary

This is a prospective, multi-center, post market registry study designed to evaluate the safety and efficacy of treatment with Balt coils in patients with chronic subdural hematoma (cSDH).

Frequently Asked Questions

What is Chronic Subdural Hematoma Embolization With Detachable Coils?

Chronic Subdural Hematoma Embolization With Detachable Coils is a clinical trial registered under NCT07291427. Current status: RECRUITING.

What is the status of NCT07291427?

The current status of NCT07291427 (Chronic Subdural Hematoma Embolization With Detachable Coils) is: RECRUITING.

When did Chronic Subdural Hematoma Embolization With Detachable Coils start?

Chronic Subdural Hematoma Embolization With Detachable Coils started on 2026-06-02.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.